Torrey Pines Law Group, PC is an intellectual property, business, and litigation law firm headquartered in San Diego, California focusing on protecting biotechnology, pharmaceutical, medical device, digital health, and convergence technology innovations. We are your biotechnology law firm for securing, building, and defending your competitive advantage.
Torrey Pines Law Group's founder, Kevin Buckley, is a biotech patent attorney having more than 20 years of experience building intellectual property portfolios for entrepreneurial businesses. His law practice includes international patent preparation and prosecution, conducting competitive intelligence and freedom-to-operate analysis, legal opinion drafting, intellectual property litigation, intellectual property valuation, pharmaceutical lifecycle management, and conducting intellectual property due diligence in anticipation of private investments and acquisitions. For many years, Kevin has been recognized nationally for his biotechnology law practice by The Best Lawyers in America®.
The firm serves innovators with protecting intellectual property throughout the U.S., including in major biotech hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC) and throughout Southern California in Los Angeles, Orange County, and Irvine. We also respresent clients throughout the world and act as foreign agents for international patent filings.
Kevin's ultimate goal is to help you leverage each step of the commercialization process to enhance investor and grant funding, licensing and royalty revenue, regulatory approval, and reaching the market more efficiently. Regardless of the scope of your business needs, Torrey Pines Law Group is your biotechnology law firm that helps you identify likely legal obstacles and provides practical solutions to reduce your business risk and advance your business goals.